aspirin

tylenol

amyl nitrate

gravol

Aspirin

N-aceteyl-p-aminophenol

Dextrose 50%

Amyl Nitrate

NSAID

acetaminophen USP

Glucagon

Tylenol

Adsorbent

Platelet inhibitor, anti-inflammatory

Carbohydrate, Antihypoglycemic agent

Analgesic, antipyretic

Reduces production of thromboxane which mediates platelet aggregation.

Binds with hemoglobin to help biodegrade cyanide

Antipyretic action by acting on heat regulating centers in the hypothalamus causing increased heat loss through vasodilation and sweating Analgesic action by inhibiting prostaglandin synthesis in the central nervous system

Not precisely known, but evidence is that it acts to depress hyper stimulated labyrinthine functions or associated neural pathways. It is also thought to inhibit cholinergic stimulation in the vestibular and associated neural pathways.

Pyrexic child, severe sepsis or septic shock

Relief of nausea and vomiting, can be associated with motion sickness and nausea vomiting associated with Meniere’s Disease, or medication induced N/V particularly Narcotics.

Oral poisoning or overdose

Acute cyanide poisoning with impaired LOC

Hypersensitivity to ASA or other NSAIDs, active peptic ulcers

Hypersensitivity

Hypersensitivity, acetaminophen-induced liver disease

Hyperglycemia

Intracranial pressure – may worsen cerebral edema

Potentially fatal hepatotoxicity can result from overdose Patients with liver disease, are malnourished, are chronic alcoholics or are taking medications that induce hepatic enzymes are at greater risk for acetaminophen hepatotoxicity All acetaminophen containing products taken by patient need to be accounted for during 24 hour period including cough and cold remedies, analgesic or arthritis formulations, and antipyretics

Patients with cardiac history, pregnancy

Do not administer to patient with decreased LOC. If ipecac has been administered, wait 10 minutes.

Drowsiness

nausea/ vomiting, cramping may be seen in overdose in children and nothing noted in adults till liver function deterioration

Tachycardia, palpitations, headache, anxiety, arrhythmias, nausea/ vomiting

Tissue necrosis, local venous irritation

PO/PR

Inhalation

IM, SQ, Nebulized

IM, IV

0.2 – 0.3 mL inhaled for 15 – 30 sec with breaks for 15 – 30 sec. New ampoule every 3 min till arrival at emergency department

160 – 325 mg

Adult: 325-650 mg every 4-6 hours, not to exceed 4000 mg/24 hours, Pediatric: 10-15 mg/kg every 4-6 hours, not to exceed 5 doses in 24 hours

12 years and older: 1 mg with repeat in 15 min as needed

Onset: Less than 1 min Peak effects: Varies Duration: Varies

Onset: Immediate Peak effects: approximately 48 min Duration: 4-6 hours

Onset: Immediate Peak effects: Varies Duration: Varies based on gastrointestinal function, will act until excreted

Onset: Within 20 min Peak effects: Varies Duration: 2 – 3 hours

0.2 or 0.3 mL glass ampoule

25 g in 50 mL prefilled syringe

Oral – tablet (100 mg, 200 mg, 400mg, 600mg, 800mg), chewable tablets (50 mg, 100 mg), capsules (200 mg), suspension (100 mg/2.5mL, 100 mg/5mL), oral drops (40 mg/mL)

Oral – Immediate release tablet (325 mg, 500 mg), caplet (325 mg, 500 mg), extended release caplet (650 mg), gel cap (500 mg), chewable tablet (80 mg, 160 mg), rapidly- dissolving tablet (80 mg , 160 mg), suspension (80 mg/mL, 32 mg/mL) Rectal – Suppository (120 mg, 160 mg, 325 mg, 650 mg)